Skip to content

Comparative study of Gucixiao combined with four step massage in the treatment of scapulohumeral periarthritis

Comparative study of Gucixiao combined with four step massage in the treatment of scapulohumeral periarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015260
Enrollment
Unknown
Registered
2018-03-19
Start date
2018-04-01
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scapulohumeral periarthritis

Interventions

4:Gucixiao cataplasm
2:Closed therapy
1:Gucixiao combined with four step massage

Sponsors

Gansu Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) between 45 and 65 years old; (2) western medicine diagnosis and TCM diagnosis standard which conforms to scapulohumeral periarthritis; (3) the related treatment of periarthritis of shoulder was not accepted in the last 2 weeks; (4) understanding and signing informed consent; It must meet the above four points at the same time.

Exclusion criteria

Exclusion criteria: (1) the shoulder pain and shoulder joint mobility caused by cervical spondylosis, coronary heart disease, shoulder disease (tuberculosis, tumor, suppurative arthritis, etc.) were confirmed by examination; (2) serious other systemic diseases, such as cardiovascular disease, liver, kidney or blood system disease, or mental illness, are not suitable for researchers; (3) anyone who does not conform to the inclusion criteria, can not determine the effect or the incomplete information on the effect or safety judgment; (4) do not cooperate with treatment plan arrangement; (5) According to the researchers, can reduce the possibility of judgment into the group or the group into complex patients, such as work environment change often causes lost situation; (6) The spirit or legal disability; (7) The two weeks using other drugs for the treatment of the disease or in other clinical trials.

Design outcomes

Primary

MeasureTime frame
visual analog scale (VAS);

Countries

China

Contacts

Public ContactXU YUDE

Gansu Provincial Hospital of TCM

dedepost@126.com+86 13909400606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026